Tesamorelin

Tesamorelin is a synthetic analogue of growth hormone releasing hormone (GHRH) studied for its ability to stimulate pulsatile growth hormone secretion and reduce visceral adipose tissue. Third-party tested, 99% purity.

Tesamorelin acts on pituitary GHRH receptors to stimulate endogenous GH secretion without the suppressive feedback associated with exogenous GH. FDA-approved (Egrifta) for HIV-associated lipodystrophy, with clinical data demonstrating significant visceral fat reduction. Also studied for cognitive benefits and body composition improvements in age-related GH decline. Supplied as a lyophilized powder in a sterile vial. 99% purity. Third-party tested by Janoshik Analytical.